Background illustration for clinical trials search

Paid Clinical Trials Newport

Discover 488 paid clinical trials in Newport, Rhode Island. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Project: Every Child for Younger Patients With Cancer

for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: Providence RI, Worcester MA, Boston MA, Hartford CT,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 25

Code: NCT02402244

Recruiting

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

for
Metastatic Malignant Neoplasm in the Lung,
Location: Providence RI, Boston MA, Hartford CT, New Haven CT,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT05235165

Phase3, Recruiting

A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

for
Immunoglobulin A Nephropathy (IgAN)
Location: Providence RI, Worcester MA, Boston MA, The Bronx NY,
Sponsor: Biogen

Sex: All

Age: 18+

Code: NCT06935357

Phase3, Recruiting

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

for
Acute Myeloid Leukemia
Location: Providence RI, Worcester MA, Boston MA, Hartford CT,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT04293562

Phase3, Recruiting

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Providence RI, Hartford CT, Stony Brook NY,
Sponsor: Children's Oncology Group

Sex: Female

Age: 0 - 39

Code: NCT06513962

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)

for
Acute Leukemia
Location: Providence RI, Boston MA, The Bronx NY, New York NY,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 2+

Code: NCT04811560

Phase1, Phase2, Recruiting

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

for
Acute Leukemia of Ambiguous Lineage,
Location: Providence RI, Worcester MA, Boston MA, New Haven CT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 1

Code: NCT06317662

Phase2, Recruiting

Strategy for Improving Stroke Treatment Response

for
Ischemic Stroke
Location: Providence RI, Boston MA, Hartford CT, New Haven CT,
Sponsor: Translational Sciences, Inc.

Sex: All

Age: 18+

Code: NCT05948566

Phase2, Recruiting

Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma

for
Follicular Lymphoma, Marginal Zone Lymphoma, B-cell Lymphoma
Location: Providence RI, New Brunswick NJ
Sponsor: Brown University

Sex: All

Age: 18+

Code: NCT04792502

Phase2, Recruiting

A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

for
Solid Tumors, Advanced Solid Tumors, Metastatic Solid Tumors
Location: Providence RI, Boston MA, Mineola NY, New York NY,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT05836324

Phase1, Recruiting

Computer-Based Continuing Education for Doctors in Examination and Counseling of Patients on Skin Cancer or Weight Control

for
Melanoma (Skin), Non-melanomatous Skin Cancer
Location: Providence RI, Philadelphia PA, Columbus OH, Wichita KS,
Sponsor: Rhode Island Hospital

Sex: All

Age: 18+

Code: NCT00295906

Recruiting

Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens

for
Leukemia, Myelodysplastic Syndromes,
Location: Providence RI, Hartford CT, Albany NY, Portland ME,
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 0 - 30

Code: NCT04968834

Recruiting

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

for
Melanoma
Location: Providence RI, New Haven CT, Paramus NJ, Hackensack NJ,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06246916

Phase3, Recruiting

A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Providence RI, New Haven CT, Toronto, Detroit MI,
Sponsor: Eikon Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06253130

Phase1, Phase2, Recruiting

A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Providence RI, Fairfax VA, Toronto, Sarasota FL,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT05765851

Phase1, Recruiting

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

for
Meningioma
Location: Providence RI, Boston MA, New York NY, Fairfax VA,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT07428616

Phase2, Recruiting

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

for
Cancer Harboring BRAF Alterations, HGG, LGG, Solid Tumors
Location: Providence RI, Boston MA, Norwalk CT, New York NY,
Sponsor: Fore Biotherapeutics

Sex: All

Age: 8+

Code: NCT05503797

Phase2, Recruiting

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
Location: Providence RI, Boston MA, Burlington MA, New Haven CT,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06119581

Phase3, Recruiting

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Providence RI, Boston MA, New Haven CT, New York NY,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT03972657

Phase1, Phase2, Recruiting

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

for
Neoplasms, Child, Adolescent
Location: Providence RI, New York NY, Washington D.C. DC,
Sponsor: Eli Lilly and Company

Sex: All

Age: 1 - 39

Code: NCT05999994

Phase2, Recruiting